{
    "xml": "<topic id=\"PHP100216\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/nimenrix\" basename=\"nimenrix\" title=\"Nimenrix\">\n<title>Nimenrix<tm tmtype=\"reg\"/>\n</title>\n<topic id=\"PHP100225\" outputclass=\"indicationsAndDose\" rev=\"1.30\" parent=\"/clinical-medicinal-product-information/nimenrix\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Immunisation against <ph outputclass=\"organism\">\n<i>Neisseria meningitidis</i>\n</ph>\n</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;17 years</p>\n<p>0.5&#8239;mL for 1 dose, to be injected preferably into deltoid region (or anterolateral thigh in child 1&#8211;2 years), then 0.5&#8239;mL after 1&#8239;year if required for 1 dose, second dose should be considered in those who continue to be at risk of <i>Neisseria meningitidis</i> serogroup A infection.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.5&#8239;mL for 1 dose, to be injected preferably into deltoid region, then 0.5&#8239;mL after 1&#8239;year if required for 1 dose, second dose should be considered in those who continue to be at risk of <i>Neisseria meningitidis</i> serogroup A infection.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP100216",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/nimenrix",
    "basename": "nimenrix",
    "title": "Nimenrix",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Immunisation against Neisseria meningitidis",
                        "html": "Immunisation against <ph outputclass=\"organism\"> <i>Neisseria meningitidis</i> </ph>",
                        "organism": "Neisseria meningitidis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection"
                    ],
                    "textContent": "By intramuscular injection",
                    "html": "By intramuscular injection",
                    "organism": "Neisseria meningitidis"
                },
                "child": [
                    {
                        "textContent": "0.5 mL for 1 dose, to be injected preferably into deltoid region (or anterolateral thigh in child 1&#8211;2 years), then 0.5 mL after 1 year if required for 1 dose, second dose should be considered in those who continue to be at risk of Neisseria meningitidis serogroup A infection.",
                        "html": "<p>0.5&#8239;mL for 1 dose, to be injected preferably into deltoid region (or anterolateral thigh in child 1&#8211;2 years), then 0.5&#8239;mL after 1&#8239;year if required for 1 dose, second dose should be considered in those who continue to be at risk of <i>Neisseria meningitidis</i> serogroup A infection.</p>",
                        "ageGroup": "1&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "0.5 mL for 1 dose, to be injected preferably into deltoid region, then 0.5 mL after 1 year if required for 1 dose, second dose should be considered in those who continue to be at risk of Neisseria meningitidis serogroup A infection.",
                        "html": "<p>0.5&#8239;mL for 1 dose, to be injected preferably into deltoid region, then 0.5&#8239;mL after 1&#8239;year if required for 1 dose, second dose should be considered in those who continue to be at risk of <i>Neisseria meningitidis</i> serogroup A infection.</p>"
                    }
                ]
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}